Literature DB >> 10436404

Association between vitamin D receptor gene polymorphism and nephrolithiasis.

M Ruggiero1, S Pacini, M Amato, S Aterini, V Chiarugi.   

Abstract

AIMS: To study the distribution of vitamin D receptor (VDR) gene alleles in hypercalciuric and nonhypercalciuric nephrolithiasis patients, hypothesizing that distinct biochemical parameters would be associated with different VDR genotypes.
METHODS: 12 hypercalciuric, 15 normocalciuric nephrolithiasis patients, and 150 healthy subjects were recruited. The individual genetic pattern for VDR was evaluated by DNA extraction followed by polymerase chain reaction amplification of the VDR gene and digestion with the restriction enzyme BsmI.
RESULTS: In the hypercalciuric group, Bb patients represented 50% (6/12); bb patients 33% (4/12), and BB cases were 16% (2/12). The VDR frequency distribution was not statistically different in hypercalciuric patients and controls (Bb 72%; bb 16%; BB 12%). In the nonhypercalciuric group, the prevalence of the bb genotype (7/15; 47%) was thrice the percentage of control subjects, while the percentage of BB patients was similar to that of the control group (2/15; 13%). Patients with the bb haplotype exhibited a higher daily urinary calcium excretion. Among hypercalciuric patients, after a calcium-restricted diet, bb patients showed a 39% reduction in daily urinary calcium excretion in comparison with a nonsignificant 13% reduction observed in BB subjects (p = 0.004).
CONCLUSIONS: The effects of VDR gene polymorphism on calcium metabolism contribute to the understanding of the pathogenesis of urinary calculi.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10436404     DOI: 10.1159/000057443

Source DB:  PubMed          Journal:  Miner Electrolyte Metab        ISSN: 0378-0392


  12 in total

1.  Profile of David J. Mangelsdorf.

Authors:  Prashant Nair
Journal:  Proc Natl Acad Sci U S A       Date:  2010-09-27       Impact factor: 11.205

2.  Vitamin D receptor gene polymorphisms in patients with urolithiasis.

Authors:  Sezgin Gunes; Cenk Yucel Bilen; Nurten Kara; Ramazan Asci; Hasan Bagci; Ali Faik Yilmaz
Journal:  Urol Res       Date:  2006-01-06

3.  Coding region analysis of vitamin D receptor gene and its association with active calcium stone disease.

Authors:  Abbas Basiri; Nasser Shakhssalim; Massoud Houshmand; Amir H Kashi; Mohaddeseh Azadvari; Banafsheh Golestan; Esmaeel Mohammadi Pargoo; Hamid Pakmanesh
Journal:  Urol Res       Date:  2011-08-04

4.  Association of vitamin-D and calcitonin receptor gene polymorphism in paediatric nephrolithiasis.

Authors:  Hemant Kumar Bid; Himanshu Chaudhary; Rama Devi Mittal
Journal:  Pediatr Nephrol       Date:  2005-04-26       Impact factor: 3.714

5.  Vitamin D receptor gene (VDR) polymorphisms and the urolithiasis risk: an updated meta-analysis based on 20 case-control studies.

Authors:  Wentao Liu; Minfeng Chen; Mengjun Li; Hong Ma; Shiyu Tong; Ye Lei; Lin Qi
Journal:  Urolithiasis       Date:  2013-11-05       Impact factor: 3.436

6.  Association of vitamin D receptor genotypes with calcium excretion in nephrolithiatic subjects in northern India.

Authors:  Vandana Relan; Madhu Khullar; S K Singh; S K Sharma
Journal:  Urol Res       Date:  2004-03-18

7.  Hypocitraturia: pathophysiology and medical management.

Authors:  Jack M Zuckerman; Dean G Assimos
Journal:  Rev Urol       Date:  2009

8.  Associations of blood pressure and hypertension with lead dose measures and polymorphisms in the vitamin D receptor and delta-aminolevulinic acid dehydratase genes.

Authors:  B K Lee; G S Lee; W F Stewart; K D Ahn; D Simon; K T Kelsey; A C Todd; B S Schwartz
Journal:  Environ Health Perspect       Date:  2001-04       Impact factor: 9.031

9.  Frequency of rare allelic variation in candidate genes among individuals with low and high urinary calcium excretion.

Authors:  Hakan R Toka; Giulio Genovese; David B Mount; Martin R Pollak; Gary C Curhan
Journal:  PLoS One       Date:  2013-08-26       Impact factor: 3.240

Review 10.  Genetics of kidney stone disease.

Authors:  Sarah A Howles; Rajesh V Thakker
Journal:  Nat Rev Urol       Date:  2020-06-12       Impact factor: 14.432

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.